ABO-202(Arbor Biotechnologies)

N/A

Report date: 2025/08/13 16:51:11

Base Information

Drug NameABO-202(Arbor Biotechnologies)
Drug Alias NameABO-202
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene expression inhibitorsStathmin 2 modulators
TargetsStathmin 2
Therapy Area/IndicationsAmyotrophic Lateral SclerosisCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArbor Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesArbor Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A